Provided by Tiger Trade Technology Pte. Ltd.

Quince Therapeutics, Inc.

0.1392
+0.00221.61%
Pre-market: 0.15310.0139+9.99%04:44 EST
Volume:21.21M
Turnover:3.06M
Market Cap:7.75M
PE:-0.12
High:0.1555
Open:0.1397
Low:0.1354
Close:0.1370
52wk High:4.55
52wk Low:0.1251
Shares:55.68M
Float Shares:49.56M
Volume Ratio:0.43
T/O Rate:42.80%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.2092
EPS(LYR):-1.3136
ROE:-247.78%
ROA:-22.10%
PB:7.32
PE(LYR):-0.11

Loading ...

What Sparked Quince Therapeutics (QNCX) Stock To Rise 53% After Hours

Benzinga_recent_news
·
Feb 13

NASD Most Active Issues

Dow Jones
·
Feb 13

BRIEF-Quince Therapeutics - On Feb 9, Engaged Lifesci Capital For Strategic Alternatives - SEC Filing

Reuters
·
Feb 12

Quince Therapeutics - Plans to Focus on Reverse Merger - SEC Filing

THOMSON REUTERS
·
Feb 12

Quince Therapeutics: Do Not Have Resources to Pursue Further Operations on Lead Drug Candidate, Edsp

THOMSON REUTERS
·
Feb 12

Quince Therapeutics - on Feb 9, Engaged Lifesci Capital for Strategic Alternatives - SEC Filing

THOMSON REUTERS
·
Feb 12

Quince Therapeutics - Lead Drug Candidate Edsp Fails in Neat Trial - SEC Filing

THOMSON REUTERS
·
Feb 12

Quince Therapeutics Stock Extends Rally On Strategic Review

Benzinga
·
Feb 12

Why Is Quince Therapeutics Stock (QNCX) Up Today?

TIPRANKS
·
Feb 10

Why Is Quince Therapeutics Stock Soaring Tuesday?

Benzinga
·
Feb 10

Quince Therapeutics Engages LifeSci Capital to Pursue Strategic Alternatives

Reuters
·
Feb 10

Quince Therapeutics Engages Lifesci Capital as Its Exclusive Financial Advisor to Explore Strategic Alternatives

THOMSON REUTERS
·
Feb 10

Five Directors Resign from Quince Therapeutics Board

Reuters
·
Feb 03

Quince Therapeutics Cut to Hold From Buy by D. Boral Capital

Dow Jones
·
Jan 30

Quince Ends Development of Lead Drug Candidate; Shares Slide

Dow Jones
·
Jan 30

BUZZ-Quince Therapeutics drops after co's drug fails to meet main goal in late-stage trial

Reuters
·
Jan 30

Quince down 14% after NEAT study endpoint did not reach statistical significance

TIPRANKS
·
Jan 30

Quince Therapeutics trading halted, news pending

TIPRANKS
·
Jan 30

Quince Therapeutics Ends Development of eDSP After Phase 3 Trial Misses Key Endpoints

Reuters
·
Jan 30

Quince Therapeutics - to Cease Clinical Development of Edsp

THOMSON REUTERS
·
Jan 30